MDS rebounds from reactor shutdown

MDS INC. $20 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.4 million; Market cap: $2.4 billion; SI Rating: Average) operates in three medical-related fields: contract drug research (roughly 45% of revenue), analytical devices (35%) and medical isotopes for cancer treatments (20%).

The stock… Read More

Costly FDA Review Coming to an End

MDS INC. $22 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.5 million; Market cap: $2.7 billion; SI Rating: Average) has completed reviews of about 85% of the tests performed at its Montreal drug-testing lab, as requested by the U.S. Food and Drug… Read More

Two Struggling Techs: 1 Buy, 1 Hold

MDS INC. $22 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 122.5 million; Market cap: $2.7 billion; SI Rating: Average) operates in three medical -related fields: contract drug research, analytical devices and medical isotopes.

The company now spends about 2% of its revenue on… Read More

Buyback Brightens MDS’s Outlook

MDS INC. $22 (Toronto symbol MDS; Conservative Growth Portfolio, Consumer sector; Shares outstanding: 121.9 million; Market cap: $2.7 billion; SI Rating: Average) has repurchased 15.8% of its outstanding common shares at $21.90 each under a Dutch Auction. The buyback cost MDS $499.3 million. To put… Read More